Digital Silver Forum Showcases Health, Technology, and Business Innovation for $15 Trillion Silver Market

The unique one-day event brought focus on active and healthy ageing ahead of Slush, Europe’s largest startup conference

HELSINKI, FINLAND (November 29, 2017) – On November 28, the second-annual Digital Silver Forum convened nearly 400 leaders from global businesses, startups, NGOs, governments, and policymaking organizations for a day-long event in Helsinki to connect digital innovation and healthy and active ageing for the $15 trillion silver market. Digital Silver brought focus to the increasing recognition and response to the growing influence of consumers over 60, of which there will be 1 billion by 2020. Researchers have previously discovered that Europe’s consumption growth is coming from the 60-75 age group, demonstrating the relevance of this consumer group to the business sector. The forum also supports entrepreneurs who are 55 and older – representing more than 23 percent of new business leaders according to data in the U.S., which is likely a reflection of global trends.

“Europe, like much of the world, is experiencing a rapid change in our societies,” said Esko Aho, former Prime Minister of Finland and co-organizer of the event. “Increased longevity and plummeting birth rates mean that we must dramatically rethink how we organize our societies, plan for the future, and do business. At Digital Silver we saw impressive approaches to meeting the needs of the emerging digital silver market.”

Digital Silver was the official pre-Slush event focused on health and technology innovation for the rapidly growing silver market and brought together business leaders from across multiple sectors and global policymaking institutions, including Bayer,  BioSig Technologies, Bordeaux Institute of Technology, EasyCare Academy, GlycoLeap, the Government of Finland, Inria, Intel, IBM, Kela, Nokia, OP Financial, Sitra, Sky Labs, Tekes, University of Jyväskylä, Vertical Health Accelerator, and many more. Digital Silver was also proud to have prominent public policy leaders, including Dr. John Beard, Head of Ageing and Life Course for the World Health Organization, Carlos Moedas, Commissioner for Research, Science and Innovation, European Commission, and Annika Saarikko, Minister of Family Affairs and Social Services in Finland.

“In little more than two years, there will be one billion globally over the age of 60,” said Michael Hodin, CEO of the Global Coalition on Aging and the other co-organizer of the event. “Older consumers will control an ever greater percentage of disposable income, as much as 70% in the United States. A diverse group with varying needs, desires, and abilities, the over-60 consumer presents a challenge to our traditional thinking, but more importantly, a tremendous opportunity for businesses and for policymakers.”

“We are trying to tackle the attitudes that are pervasive across society on ageing at the moment and realign health systems so they are much better oriented to the needs of older people.  Every country on the planet needs a system of long term care and age-friendly environments,” said John Beard, Director of the Department of Ageing and Life Course at the World Health Organization (WHO). “We need a global consensus on how we are approaching ageing societies, and how we define success. The private sector is a critical stakeholder, and the Digital Silver Forum has moved this agenda forward as a place to share ideas and push the boundaries of innovation.”

Digital Silver showcased some of the most innovative initiatives to meet the needs of older adults from policymakers and business alike. Highlights include:

  • Interviewed by Esko Aho, Former Prime Minister of Finland, EasyCare Academy’s co-founder Peter Nicholson, spoke about the ambitious new social enterprise and its plans to use data and a cutting-edge technology platform to enable the world to meet its rapidly growing need for high-quality elder care.
  • Speakers from Bayer, Nokia, and Kela discussed how major companies are viewing the challenges and opportunities in creating new products and adapting existing ones to meet the needs of older consumers in ways that reflect the diverse and unique needs of this group.
  • Ryoji Noritake, the Executive Director of Japan’s Health and Global Policy Institute shared important insights into what our future will look like, and how we can prepare based on Japan’s experience on the leading edge of grappling with a rapidly ageing population.
  • Leaders from Intel, IBM, Sky Labs, Holmusk, and Inria provided demonstrations to attendees of technologies for seniors that may enable them to stay healthy and active, live independently for longer, or simply exist to bring delight.
  • Ambitious new start-ups looking to break into the Silver Market competed for prize money and mentorship in front of a panel of judges from Bayer, BioSig Technologies, and Icecapital Securities.

Digital Silver was organized by the Global Coalition on Aging and Verbatum Oy, and sponsored by OP Financial and EasyCare Academy. The event was supported by Tekes, Tela, Bayer, Nokia, and Vertical, with additional assistance from Helsinki Business Hub, Sitra, and Evondos.

For a full list of speakers and expanded commentary from WHO’s John Beard, please visit www.digitalsilver.eu.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.